Your browser doesn't support javascript.
loading
Absence of cardiovascular manifestations in a haploinsufficient Tgfbr1 mouse model.
Renard, Marjolijn; Trachet, Bram; Casteleyn, Christophe; Campens, Laurence; Cornillie, Pieter; Callewaert, Bert; Deleye, Steven; Vandeghinste, Bert; van Heijningen, Paula M; Dietz, Harry; De Vos, Filip; Essers, Jeroen; Staelens, Steven; Segers, Patrick; Loeys, Bart; Coucke, Paul; De Paepe, Anne; De Backer, Julie.
Afiliação
  • Renard M; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Trachet B; Institute Biomedical Technology - Biofluid, Tissue and Solid Mechanics for Medical Applications, Ghent University, Ghent, Belgium.
  • Casteleyn C; Department of Morphology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium ; Department of Veterinary Sciences, Faculty of Pharmaceutical, Biochemical and Veterinary Sciences, University of Antwerp, Wilrijk, Belgium.
  • Campens L; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Cornillie P; Department of Morphology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
  • Callewaert B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Deleye S; Institute Biomedical Technology - Medical Image and Signal Processing Unit, Ghent University, Ghent, Belgium ; Molecular Imaging Center, University of Antwerp, Wilrijk, Belgium.
  • Vandeghinste B; Institute Biomedical Technology - Medical Image and Signal Processing Unit, Ghent University, Ghent, Belgium.
  • van Heijningen PM; Departments of Cell Biology and Genetics, Radiation Oncology and Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands.
  • Dietz H; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America ; Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • De Vos F; Laboratory of Radiopharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
  • Essers J; Departments of Cell Biology and Genetics, Radiation Oncology and Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands.
  • Staelens S; Institute Biomedical Technology - Medical Image and Signal Processing Unit, Ghent University, Ghent, Belgium ; Molecular Imaging Center, University of Antwerp, Wilrijk, Belgium.
  • Segers P; Institute Biomedical Technology - Biofluid, Tissue and Solid Mechanics for Medical Applications, Ghent University, Ghent, Belgium.
  • Loeys B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium ; Center for Medical Genetics, Antwerp University Hospital, Edegem, Belgium.
  • Coucke P; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • De Paepe A; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • De Backer J; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
PLoS One ; 9(2): e89749, 2014.
Article em En | MEDLINE | ID: mdl-24587008
ABSTRACT
Loeys-Dietz syndrome (LDS) is an autosomal dominant arterial aneurysm disease belonging to the spectrum of transforming growth factor ß (TGFß)-associated vasculopathies. In its most typical form it is characterized by the presence of hypertelorism, bifid uvula/cleft palate and aortic aneurysm and/or arterial tortuosity. LDS is caused by heterozygous loss of function mutations in the genes encoding TGFß receptor 1 and 2 (TGFBR1 and -2), which lead to a paradoxical increase in TGFß signaling. To address this apparent paradox and to gain more insight into the pathophysiology of aneurysmal disease, we characterized a new Tgfbr1 mouse model carrying a p.Y378* nonsense mutation. Study of the natural history in this model showed that homozygous mutant mice die during embryonic development due to defective vascularization. Heterozygous mutant mice aged 6 and 12 months were morphologically and (immuno)histochemically indistinguishable from wild-type mice. We show that the mutant allele is degraded by nonsense mediated mRNA decay, expected to result in haploinsufficiency of the mutant allele. Since this haploinsufficiency model does not result in cardiovascular malformations, it does not allow further study of the process of aneurysm formation. In addition to providing a comprehensive method for cardiovascular phenotyping in mice, the results of this study confirm that haploinsuffciency is not the underlying genetic mechanism in human LDS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Receptores de Fatores de Crescimento Transformadores beta / Anormalidades Cardiovasculares / Modelos Animais de Doenças / Síndrome de Loeys-Dietz / Haploinsuficiência Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Receptores de Fatores de Crescimento Transformadores beta / Anormalidades Cardiovasculares / Modelos Animais de Doenças / Síndrome de Loeys-Dietz / Haploinsuficiência Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article